org placeholder image

Matthew Henn

Board of Advisors at Seres Therapeutics

  • twitter
  • LinkedIn

Biotech executive with a passion for building teams and collaborative partnerships that deliver innovative strategies to advance microbial-based technologies that enable the development o...

Read More

map
SERES THERAPEUTICS

SERES THERAPEUTICS

  • Employees count Employees 201-500
  • Revenue Revenue 100 Million to 250 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Seres Therapeutics Org Chart and Mapping

Eric Shaff

President, Chief Executive Officer

VP-Level

Kevin Mannix

SVP, Investor Relations & Corporate Communications

Employees

Anthony Brozusky

Principal Associate Quality Management Systems

Josh Maloney

Senior Systems Administrator

Emma Howard

Quality Control Associate

Jacqueline West

Senior Manufacturing Specialist

Subhayu Basu

Director, Technical Development

Frequently Asked Questions Regarding Matthew Henn

Answer: Matthew Henn works for Seres Therapeutics as Board of Advisors

Answer: Matthew Henn’s role in Seres Therapeutics is Board of Advisors

Answer: Matthew Henn's email address is m***@gmail.com

Answer: Matthew Henn's business email address is m****@serestherapeutics.com

Answer: Matthew Henn’s direct phone number is (***)-***-****

Answer: Matthew Henn works in the industry of: Biotechnology

Answer: Matthew Henn is the current Board of Advisors at Seres Therapeutics.... Read More

Answer: Matthew Henn works Seres Therapeutics located at 200 Sidney St Fl 4, Cambridge, Massachusetts, 02139, United States

Answer: Seres Therapeutics's Board of Advisors is Matthew Henn

Answer: Matthew Henn contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@serestherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access